Doctor Michal Farkowski
National Institute of Cardiology, Warsaw (Poland)
Member of:
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Difficult decisions in patients with cancer and arrhythmia/devices
Event: EHRA 2024
Topic: Public Health and Health Economics, Other
Session type: Symposium
Sustainability and arrhythmia treatment: what are the arguments?
Event: EHRA 2024
Topic: Public Health and Health Economics, Other
Session type: Symposium
Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Risk factors and outcome in patients with atrial fibrillation
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Remodelling, prognosis, and outcomes in atrial fibrillation
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Evidence-based EP sustainability: what is the current state of knowledge
Event: EHRA 2023
Topic: Public Health and Health Economics, Other
Session type: Symposium
Sustainability of EP procedures in 2023
Event: EHRA 2023
Topic: Public Health and Health Economics, Other
Session type: Case-Based Session
Novel insights in atrial fibrillation ablation procedures
Event: ESC Congress 2022
Topic: Treatment
Session type: Abstract Sessions
Innovations in supraventricular tachycardia management
Event: ESC Congress 2022
Topic: Supraventricular Tachycardia (Non-Atrial Fibrillation)
Session type: Abstract Sessions
ESC 365 is supported by
